Biofil Chemicals schedules its board meeting for May 30, 2026, to approve audited financial results for Q4 and FY ending March 31, 2026.
The meeting agenda includes reviewing the audited financial statements, auditors' report, and statement of assets, liabilities, and cash flow.
The company's trading window for insiders will reopen 48 hours after the declaration of the audited financial results.